Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 15Breast Neoplasms 11Neoplasms 8Fatigue 8Cognitive Dysfunction 3Lung Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Postoperative Bowel Functions 1Polycystic Ovary Syndrome 1Parasomnias 1Obesity 1Multiple Endocrine Neoplasia Type 1 1Metabolic Syndrome 1Lymphoma, Follicular 1Liver Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1Asthenia 1Arthritis 1Arthralgia 1Adenomatous Polyps 1

Interventions

Gemcitabine 94Cisplatin 71Capecitabine 39Oxaliplatin 38durvalumab 29Fluorouracil 27pembrolizumab 26Leucovorin 23S 1 (combination) 19Nivolumab 14Irinotecan 14lenvatinib 13Bevacizumab 11tremelimumab 10130-nm albumin-bound paclitaxel 9apatinib 8Trastuzumab 7Injections 7Immune Checkpoint Inhibitors 7Docetaxel 7Albumin-Bound Paclitaxel 7Paclitaxel 6Drug Therapy 6titanium silicide 5surufatinib 5irinotecan sucrosofate 5gemcitabine-oxaliplatin regimen 5envafolimab 5camrelizumab 5atezolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × Walking × Clear all
NCT01542281 2012-03-02

Pre-habilitation to Improve Outcomes in Patients Undergoing Liver Resection for Cancer

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Unknown
64 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Liver Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡